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Abstract We show here, by high resolution sodium dodecyl
sulfate gel electrophoresis, that the proportions of myosin heavy
chain (MyHC) isoforms of mouse muscles are speci¢cally
shifted by hereditary neuromuscular diseases. In wild-type and
dystrophic MDX anterior tibial muscle (TA) about 60% of the
MyHC is IIB, 30% IIX, at most 10% IIA and 6 2% type I
(slow). In myotonic fast muscles, hyperexcitability leads to a
drastic reduction of MyHC IIB which is compensated by IIA.
Slow muscles, like soleus and diaphragm, were only marginally
changed by myotonia. The MyHC pattern of TA of spinal
muscular atrophy (SMA) ‘wobbler’ mice is shifted to a faster
phenotype, with nearly 90% IIB. In the SMA mutant ‘muscle
de¢cient’, all four adult isomyosins are expressed in the TA.
These ¢ndings may be relevant for the future diagnosis of neuro-
logical disorders both in mouse disease models and in human
patients.
2 2004 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
The approach to functional genomics by constitutional
knockout of genes in the mouse has been criticized with the
argument that loss of a single gene function, i.e. a single cut in
the network of gene interactions, might alter the expression of
a host of other genes [1]. The same argument would apply to
spontaneous loss-of-function mutations. Yet, indirect changes
of gene expression or secondary e¡ects of mutations are in-
structive for the very reason that they highlight the network of
gene interactions. These interactions may be of a more direct
physical kind, by participation of di¡erent gene products in
one protein complex, as in the case of the dystrophin glyco-
protein complex that spans the sarcolemma. Alternatively, the
relation may be more indirect in that a single gene determines
a physiological property on which the expression of many
other genes depends. An example of the latter case is the
muscular chloride channel ClC-1 which regulates the excitabil-
ity of skeletal muscle. Loss of function of the corresponding
gene, Clc1, leads to hyperexcitability of muscle, the hallmark
of the disease myotonia (muscle sti¡ness) [2^4]. Neurogenic
muscle diseases like spinal muscular atrophy (SMA) in hu-
mans or mouse models of SMA like ‘wobbler’ (WR) [5,6]
and ‘muscle de¢cient’ (MDF) [7] are due to motoneuron de-
generation in the brainstem and spinal cord.
In the absence of pathological in£uences, muscle is able to
adapt its ¢ber type pro¢le to changing physiological and func-
tional demands. This plasticity is re£ected in the selective ex-
pression of the myosin heavy chain (MyHC) isoforms, the
myo¢brillar components that determine the speed of contrac-
tion. The four myosin isoforms expressed in adult mouse skel-
etal muscle (in order of decreasing contraction rate) are fast
IIB, IIX (= IID), and IIA, and slow I. The IIB MyHC is
expressed in the large diameter glycolytic ¢bers whereas the
other isoforms are found in the more oxidative ¢bers. In
muscles of small mammals, arti¢cial chronic stimulation in-
duces a ¢ber type shift from fast glycolytic in the direction of
slow oxidative whereas disuse or decreased motor activity
causes the opposite transformation (reviews [8^11]).
Hyperexcitable muscles of myotonic mice are transformed
from a mixed glycolytic/oxidative to a pure oxidative pheno-
type [12,13]. This shift can be partially reversed by drugs that
suppress the hyperexcitability [14,15]. Other consequences of
myotonia in the mouse muscles are a downregulation of
MyHC IIB [14,15] as well as of the calcium binding protein
parvalbumin [16] and its mRNA [15,17]. The shift of isomyo-
sin phenotype from fast glycolytic to slow oxidative in the
myotonic muscle was con¢rmed at the level of mRNA
[18,19] and was related to a di¡erential expression of the
myogenic factors: MyoD mRNA content was lowered, where-
as myogenin mRNA was elevated [19].
An isomyosin shift in the direction fast to slow has also
been observed in muscle biopsies from myotonia patients
[20]. In Thomsen^Becker myotonia the loss of function of
the muscle chloride channel causes milder symptoms than in
the mouse and therefore there are less dramatic changes in
muscle biochemistry than were observed in the myotonic
mouse. Paradoxically, for the myotonic goat which also has
a mutation in the muscle chloride channel a ¢ber type shift
from slow to fast, i.e. in a direction opposite to that caused by
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homologous mutations in mouse and man, has been reported
[21].
Here we present, for the ¢rst time, a relation between the
proportion of all major skeletal myosin isoforms to distinct
hereditary diseases using mouse models of myotonia, muscu-
lar dystrophy and spinal muscular atrophy (SMA) or amyo-
trophic lateral sclerosis (ALS). Our results document the high
speci¢city of isomyosin switches with respect to both the gene
defect and the anatomical identity of the muscle. They could
provide a tool to diagnose uncharacterized neurological dis-
eases both in genetically manipulated mice and in patient
biopsies.
2. Materials and methods
Adult dystrophic MDX, myotonic ADR, MTO and ADR*K, dou-
ble mutant ADR.MDX, and atrophic WR and MDF mutant muscles
(Table 1 [22]) were compared to muscles from una¡ected littermates.
The longissimus dorsi, tibialis anterior (TA), extensor digitorum lon-
gus, gastrocnemius, soleus, tongue, masseter and diaphragm muscles
were dissected from freshly killed adult mice (70^150 days of age),
immediately frozen in liquid nitrogen and stored at 380‡C. At least
three mice were used for each experimental point. Frozen muscles
were extracted on ice for 60 min in four volumes of extracting bu¡er
(pH 6.5) as previously described [23]. Following centrifugation, the
supernatants were diluted 1:1 with glycerol and stored at 320‡C.
MyHCs were separated on 8% polyacrylamide gels which were
made in the Bio-Rad mini-Protean II Dual slab gel cell system (0.75
mm thickness) as described previously [24]. Electrophoresis was car-
ried out for 31 h at 72 V (constant voltage) at 4‡C. Following elec-
trophoresis, the gels were silver-stained according to [25]. The gels
were scanned using a video acquisition system. The relative levels of
MyHC isoforms were determined using a densitometric software
(Scion Image, NIH, USA).
3. Results
Using high-resolution gel electrophoresis, the patterns of
MyHC in TA muscle of adult myotonic mice (ADR,
ADR*K, MTO, double mutant ADR.MDX) were compared
to those of muscles a¡ected by muscular dystrophy (MDX)
and SMA/ALS-like atrophies WR and MDF (Table 1, Fig. 1).
In normal adult mice the TA muscle contained predominantly
fast IIB (62.4 T 4.1% (S.D.) of the total MyHC content) and
IIX (30.7 T 2.8%) myosin isoforms and a small amount
(6.6 T 3.4%) of fast IIA isoform. In the TA muscle of adult
MDX mutant mice no major change was observed as com-
pared to wild-type (Fig. 1). The pattern of MyHC expression
in myotonic mice was characterized by an increase of MyHC
IIA at the expense of IIB which was reduced from about 60 to
5^15%. This shift was similar regardless of the alleles or the
di¡erent genetic backgrounds of the myotonic mutants, but
MTO muscle showed the strongest reduction in MyHC IIB. It
is not clear whether this slight di¡erence is due to the allele or
to the genetic background, SWR/JUC57BL/6 hybrid. The
mutant ADR*K is distinct from the two other alleles in that
the ClC-1 antigen is retained in the sarcolemma (C. Wiegand
and H. Jockusch, 2000, unpublished). The MyHC pattern in
the TA of the double mutant ADR.MDX [26] was indistin-
guishable from that of the ADR mice (Fig. 1A).
The two mouse mutants with ALS/SMA-like diseases, WR
and MDF, showed MyHC patterns distinct from myotonic
muscles as well as from each other. In the TA muscle of
WR mice a shift to a fast glycolytic phenotype was observed:
the amount of IIA and particularly IIX MyHC was decreased
and the amount of IIB MyHC was increased. In the TA
muscle of the other SMA mutant, MDF, there was a moder-
Table 1
Mouse mutants used in this study
Disease/phenotype Gene Chromosome Phenotype Background References
Arrested development of righting response, ADR Clc1 6 myotonia A2G [2,13]
Arrested development of righting response kansas, ADR*K Clc1 6 myotonia C57BL/6 [31,32]
Myotonia, MTO Clc1 6 myotonia SWR/J, C57BL/6 [32,33]
Wobbler, WR wr 11 atrophy C57BL/6 [5,6]
Muscle de¢cient, MDF mdf 19 severe atrophy C57BL/6 [7]
X-linked muscular dystrophy, MDX Dmd X dystrophy C57BL/10 [34,35]
Double mutant, ADR.MDX Clc1, Dmd 6, X myotonia A2G, C57BL/10 [26]
Fig. 1. MyHC isoforms in the TA muscles of mouse mutants af-
fected by the neuromuscular disorders myotonia (ADR, ADR*K,
MTO), muscular dystrophy (MDX), and spinal muscular atrophy
(WR, MDF) in comparison to wild-type (WT) controls. A: Separa-
tion of four MyHC isoforms by high-resolution sodium dodecyl sul-
fate gel electrophoresis. Isoforms are fast IIB, IIX and IIA and
slow type I. Migration from top to bottom (anode). B: Proportions
of MyHC isoforms as determined by densitometric analysis of sil-
ver-stained bands. For details of mutants see Table 1.
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ate loss of MyHC IIB and slow MyHC I, normally absent
from TA, was expressed (Fig. 1).
In order to determine if a shift to a slower MyHC pattern
also occurred in functionally distinct skeletal muscles of myo-
tonic mice, we analyzed the pattern of MyHC in the long-
issimus dorsi, soleus, tongue, diaphragm, and masseter
muscles of ADR mutant mice in comparison to control litter-
mates (Fig. 2). Signi¢cant changes were observed in all
muscles of ADR mice except the slow contracting soleus.
The longissimus dorsi is a fast, predominantly glycolytic
muscle, and a more dramatic shift to a slower MyHC pattern
than in the TA was observed: MyHC IIB, which represents
70% of the MyHC in wild-type longissimus dorsi, was totally
eliminated. The soleus is fully oxidative and contains predom-
inantly MyHCs IIA and I with about 10% MyHC IIX. Its
contractility is severely a¡ected by myotonia [14], however the
MyHC pattern was identical to that of wild-type. In the
tongue IIB MyHC expression was moderately downregulated
with a compensatory upregulation of IIX. In the masseter and
the diaphragm the wild-type pattern of MyHCs is di¡erent
from that of limb muscles. In normal mice the masseter
muscles, in addition to the three fast MyHC isoforms, con-
tained a small amount of the neonatal myosin isoform,
MyHC NN. In normal diaphragm all four adult MyHCs
(IIB, IIX, IIA, I) are present. In myotonic (ADR) masseter
and diaphragm the expression of IIB MyHC was totally elim-
inated. In the masseter the loss of IIB MyHC was compen-
sated by increased levels of both IIA and MyHC NN iso-
forms, in the diaphragm by an increased expression of IIX
MyHC.
4. Discussion
In mouse models in which the activity pattern of mamma-
lian skeletal muscle was altered by chronic stimulation, disuse
or surgical denervation, a sequence of transformations has
repeatedly been found, with the MyHC isoforms being modi-
¢ed according to decreasing rate of contraction: IIBHIIX
(D)HIIAHI (Fig. 3). Chronic stimulation in a tonic pattern
tends to shift the MyHC isoforms from left to right, i.e. fast
glycolytic to slow oxidative [10,11], whereas disuse or dener-
vation does so in the opposite direction. In the mouse, using
chronic stimulation it is not possible to shift IIB ¢bers
through the full range into type I ¢bers, which in wild-type
limb muscles are largely con¢ned to the soleus. In contrast to
arti¢cially stimulated adult animals, muscles in genetic mouse
models of di¡erent neuromuscular diseases already develop
under the in£uence of the physiological e¡ects of the muta-
tion. The muscular phenotype might be changed from the
earliest time point the mutant becomes manifest. Despite
this di¡erence, all the evidence supports the notion that the
MyHC shift observed in myotonic mice is caused by the hy-
perexcitability of muscle which leads to unscheduled episodes
of trains of action potentials, equivalent to an arti¢cial stim-
ulation in a tonic pattern. Using physiological and histochem-
ical criteria it was found that all muscles of myotonic mice
that could be tested by contraction measurements of ¢ber type
shifts were a¡ected by myotonic hyperexcitability, indicating
that these muscles do contain ClC-1 and that this is required
for normal excitability. The muscles examined included the
soleus (contraction measurements [12]), extraocular muscles
(nystagmus and ¢ber type shift [27]), cross-striated muscle of
the pharynx (¢ber type shift [27]); however, no physiological
or histochemical data were available for masseter and tongue,
muscles which, according to reverse transcription polymerase
chain reaction, contain levels of ClC-1 mRNA comparable to
Fig. 2. MyHC isoforms in di¡erent adult myotonic (ADR) and
wild-type muscles. A: Separation of ¢ve MyHC isoforms (four adult
MyHC as in Fig. 1 and one neonatal, NN, which is restricted to
the adult masseter). B: Proportions of MyHC isoforms. Abbrevia-
tions for muscles: LD, longissimus dorsi; SOL, soleus; MASS,
masseter; TON, tongue; DIA, diaphragm. WT, wild-type control.
Fig. 3. Schematic representation of MyHC isotype transitions in
mouse muscles a¡ected by neuromuscular diseases. Bar, no signi¢-
cant change; arrow, isotype shift in the direction of the arrow;
+, new appearance of a MyHC isoform in the mutant muscle;
dashed line, disappearance of a MyHC isoform in a mutant.
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those of limb and trunk muscles (C. Wiegand and H. Jock-
usch, unpublished results). We have not observed any obvious
anomaly with food uptake, chewing and swallowing in the
myotonic mice, but the masseter loses MyHC IIB and is
thus clearly a¡ected by the myotonia mutation. It is known
that myotonic cramps (which in the masseter would have
severe consequences for feeding) are suppressed by so-called
warm-up, i.e. a temporary suppression of hyperexcitability by
continuous use over several minutes. A similar argument may
hold for the tongue and the diaphragm.
In contrast to myopathies in which the a¡ected gene is ex-
pressed in muscle ¢bers, spinal muscular atrophies are char-
acterized by indirect e¡ects of a postnatal loss of motoneurons
on muscle. Although the histological appearance of neurode-
generation in the ALS/SMA mouse models wobbler [5] and
muscle de¢cient [7] are similar as are the elevated levels of
mRNAs for acetylcholine receptor K subunit, myogenin, and
MyoD and the reduced level of ClC-1 mRNA [22], we have
observed very di¡erent MyHC phenotypes. After a few weeks,
disuse or denervation tends to shift the isomyosin patterns
from slow oxidative to fast glycolytic [28], in a direction op-
posite to that caused by chronic stimulation or myotonia. This
is exactly what we have observed in the WR muscles in which
biochemical analysis con¢rms physiological denervation and
decreased activity [22]. Unexpectedly, MDF muscles show a
MyHC pattern which is shifted towards a slower phenotype
including slow MyHC I in muscles that normally do not ex-
press this isoform. The di¡erence between WR and MDF may
be due to the fact that in WR muscle denervation by moto-
neuron loss is partially compensated for by nerve sprouting
and re-innervation [5] whereas in MDF muscle denervation
may be complete and irreversible. Myographic analysis may
aid in detecting the crucial physiological di¡erence between
these two muscle atrophies.
In dystrophic MDX mouse there is a massive degeneration
of muscle ¢bers around weaning age so that the majority of
muscle ¢bers in the adult have undergone degeneration/regen-
eration processes as con¢rmed by the centrally rather than
peripherally located nuclei. The fact that adult MDX muscle
shows a wild-type pattern of MyHCs rather than a patholog-
ical ¢ber type shift is additional evidence that ongoing phys-
iological activity rather than the developmental history is the
important determinant of isomyosin expression.
Future investigations of the secondary e¡ects of myotonia
and spinal muscular atrophies might include expression pro¢l-
ing of a¡ected muscles, with the advantage that expression
di¡erences for a large number of genes are already known
[16,17,29,30] and these might serve as positive controls. For
the distinction between the secondary e¡ects of the two mouse
spinal atrophies, wobbler and MDF, to be mechanistically
understood, the identi¢cation of the a¡ected genes is probably
a prerequisite.
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